Stabile feste Formen von Regadenoson
EP2789624
Art B1
23. September 2020
Anmelder: AMRI Italy S.r.l., Euticals S.P.A. 🇮🇹
Details
- Veröffentlichungs-Nr.
- EP2789624
- Aktenzeichen
- EP13163400
- Anmeldetag
- 11. April 2013
- Veröffentlichung
- 23. September 2020
- Erteilung
- 23. September 2020
- Rechtsraum
- EP
- IPC
- C07H19/16C07H19/167
Abstract
A process for the preparation of the amorphous form of Regadenoson of formula <img class="EMIRef" id="468993210-ia01" /> is disclosed together with new crystalline polymorphic forms E, F and G and methods for their preparation. Regadenoson amorphous form can be prepared in mild reaction conditions with high chemical purity (>99.6%) and high stability to the heating. A particularly thermodynamically stable anhydrous crystalline form of Regadenoson (form G) is also disclosed, provided with high stability not when exposed to 90% RH at 25°C for 96 hour, but also to the heating up to 200°C.
Anmelder
- Firmen
- AMRI Italy S.r.l.
Euticals S.P.A. - Land
- 🇮🇹 Italien
Fachgebiete
Vertreten von
Sulcis, Roberta
Milano, Italien
24
Patente gesamt
10
Fachgebiete
5
Anmelder-Länder
Schwerpunkte
Weitere Vertreter
-
Ghirardi, Valeria
Cantaluppi & Partners S.r.l. · Milano
-
Spadaro, Marco
NoneRoma